ED
Exane Derivatives Portfolio holdings
AUM
$174M
1-Year Return
7.83%
This Quarter Return
-1.27%
1 Year Return
-7.83%
3 Year Return
+43.87%
5 Year Return
+57.06%
10 Year Return
–
AUM
$401M
AUM Growth
-$25.6M
(-6%)
Cap. Flow
-$17M
Cap. Flow
% of AUM
-4.24%
Top 10 Holdings %
Top 10 Hldgs %
23.96%
Holding
1,084
New
48
Increased
284
Reduced
325
Closed
48
Top Buys
| 1 |
UBS Group
UBS
|
$7.39M |
| 2 |
Linde
LIN
|
$6.04M |
| 3 |
Logitech
LOGI
|
$3.09M |
| 4 |
Coca-Cola
KO
|
$1.4M |
| 5 |
Amazon
AMZN
|
$943K |
Top Sells
| 1 |
Stellantis
STLA
|
$13.9M |
| 2 |
iShares S&P 500 Value ETF
IVE
|
$7.35M |
| 3 |
Alcon
ALC
|
$5.71M |
| 4 |
Ferrari
RACE
|
$5.04M |
| 5 |
CNH
CNH Industrial
CNH
|
$2.84M |
Sector Composition
| 1 | Financials | 16.09% |
| 2 | Technology | 15.88% |
| 3 | Consumer Discretionary | 11.56% |
| 4 | Healthcare | 11.39% |
| 5 | Industrials | 10.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
476
Rapid7
RPD
$1.32B
| $134K | 0.03% |
1,188
| – | – |
|
|
ATRS
477
DELISTED
Antares Pharma, Inc.
ATRS
| $132K | 0.03% |
36,385
+2,139
| +6% | +$7.79K |
|
|
CBAY
478
DELISTED
Cymabay Therapeutics
CBAY
| $132K | 0.03% |
36,133
+1,919
| +6% | +$7K |
|
479
Hydrofarm Holdings
HYFM
$15.4M
| $132K | 0.03% |
348
-67
| -16% | -$25.4K |
|
480
Nuveen Quality Municipal Income Fund
NAD
$2.68B
| $131K | 0.03% |
8,400
| – | – |
|
481
argenx
ARGX
$45.9B
| $130K | 0.03% |
429
-79
| -16% | -$23.9K |
|
482
Tenet Healthcare
THC
$17.3B
| $126K | 0.03% |
+1,889
| New | +$126K |
|
483
Paycom
PAYC
$12.6B
| $124K | 0.03% |
250
| – | – |
|
484
Kiniksa Pharmaceuticals
KNSA
$2.65B
| $123K | 0.03% |
10,773
+1,268
| +13% | +$14.4K |
|
485
Carnival Corp
CCL
$42.8B
| $122K | 0.03% |
4,895
| – | – |
|
486
Sunrun
RUN
$4.19B
| $122K | 0.03% |
2,778
-17
| -0.6% | -$748 |
|
|
GTHX
487
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $122K | 0.03% |
9,087
+2,346
| +35% | +$31.5K |
|
|
AWF
488
AllianceBernstein Global High Income Fund
AWF
$974M
| $121K | 0.03% |
9,900
-1,000
| -9% | -$12.3K |
|
489
SPDR S&P Biotech ETF
XBI
$5.39B
| $121K | 0.03% |
963
+62
| +7% | +$7.79K |
|
490
CareDx
CDNA
$736M
| $120K | 0.03% |
1,888
+253
| +15% | +$16K |
|
491
Incyte
INCY
$16.9B
| $119K | 0.03% |
1,724
+124
| +8% | +$8.53K |
|
492
Zai Lab
ZLAB
$3.42B
| $115K | 0.03% |
1,091
+306
| +39% | +$32.2K |
|
493
Iron Mountain
IRM
$27.2B
| $114K | 0.03% |
2,630
+1,767
| +205% | +$76.8K |
|
494
AllianceBernstein
AB
$4.29B
| $114K | 0.03% |
+2,290
| New | +$114K |
|
|
ONC
495
BeOne Medicines Ltd. American Depositary Shares
ONC
$37.6B
| $113K | 0.03% |
311
+72
| +30% | +$26.1K |
|
496
Cooper Companies
COO
$13.5B
| $112K | 0.03% |
1,084
-328
| -23% | -$33.9K |
|
497
Zions Bancorporation
ZION
$8.34B
| $111K | 0.03% |
1,799
+683
| +61% | +$42.3K |
|
|
NREF
498
NexPoint Real Estate Finance
NREF
$273M
| $111K | 0.03% |
5,680
-2,120
| -27% | -$41.3K |
|
499
Electronic Arts
EA
$42.2B
| $110K | 0.03% |
776
-608
| -44% | -$86.5K |
|
500
Stryker
SYK
$150B
| $110K | 0.03% |
418
-131
| -24% | -$34.5K |
|